Peroxisome proliferator-activated receptor (PPAR) alpha-regulated growth responses and their importance to hepatocarcinogenesis

Toxicology Letters

Volumn 102-103, Issue , 1998, Pages 91-96

  James, N H ^a   Gill, J H ^c   Brindle, R ^a   Woodyatt, N J ^a   Macdonald, N ^a   Rolfe, M ^a   Hasmall, S C ^a   Tugwood, J D ^b   Holden, P R ^a   Roberts, R A ^a  

^a ASTRAZENECA   (United Kingdom)

^b SOMD   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Apoptosis; DNA synthesis; Non genotoxic carcinogenesis; Peroxisome proliferator; Peroxisome proliferator activated receptor (PPAR ); Tumour necrosis factor (TNF )

Indexed keywords

NAFENOPIN; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHENOBARBITAL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; CELL GROWTH; CONFERENCE PAPER; GENETIC TRANSFECTION; HUMAN; IN VITRO STUDY; KUPFFER CELL; LIVER; LIVER CARCINOGENESIS; MOLECULAR CLONING; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; CELL DIVISION; CYTOKINES; HUMANS; LIVER; LIVER NEOPLASMS; MICE; PEROXISOME PROLIFERATORS; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

RODENTIA;

EID: 0032435382     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(98)00291-4     Document Type: Conference Paper

References (40)

1. Akerman, P., Cote, P., Yang, S., et al., 1992. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am. J. Physiol. 263, 579-585.
2. Aldridge, T.C., Tugwood, J.D., Green, S., 1995. Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription. Biochem. J. 306, 473-479.
3. Alison, M.R., Sarraf, C.E., 1995. Apoptosis: regulation and relevance to toxicology. Hum. Exp. Toxicol. 14, 234-247.
4. Ashby, J., Brady, A., Elcombe, C.R., et al., 1994. Mechanistically-based human hazard assessment of peroxisome-proliferator-induced hepatocarcinogenesis. Hum. Exp. Toxicol. 13, S1-S117.
5. Bayly, A.C., Roberts, R.A., Dive, C., 1994. Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator, nafenopin. J. Cell Biol. 125, 197-203.
6. Bayly, A.C., Roberts, R.A., Dive, C., 1997. In: Advances in Molecular and Cell Biology: Mechanisms of Cell Toxicity, vol. 20. JAI Press, London, pp. 183-229.
7. Bentley, P., Calder, I., Elcombe, C., Grasso, P., Wiegand, H.G., Stringer, D.A., 1992. Hepatic Peroxisome Proliferation. ECETOC Monograph 17.
8. Bentley, P., Calder, I., Elcombe, E., Grasso, P., Stringer, D., Wiegand, H.J., 1993. Hepatic peroxisome proliferation in rodents and its significance to humans. Fd. Chem. Toxic. 31, 857-907.
9. Bieri, F., Staubli, W., Waechter, F., Muakkasah-Kelly, S., Bentley, P., 1988. Stimulation of DNA synthesis but not of peroxisomal beta-oxidation by nafenopin in primary cultures of marmoset hepatocytes. Cell Biol. Int. Rep. 12, 1077-1087.
10. Bojes, H.K., Thurman, R.G., 1996. Peroxisome proliferators activate kupffer cells in vivo. Cancer Res. 56, 1-4.
11. Bojes, H.K., Germolec, D.R., Simeonova, P., et al., 1997. Antibodies to tumor necrosis factor-alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator WY-14,643. Carcinogenesis 18, 669-674.
12. Bursch, B., Lauer, B., Timmerman-Trosiener, I., Barthel, G., Schuppler, J., Schulte-Hermann, R., 1984. Controlled death (apoptosis) of normal and preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis 5, 453-458.
13. Bursch, W., Oberhammer, F., Schulte-Hermann, R., 1992. Cell death by apoptosis and its protective role against disease. Trends Physiol. Sci. 13, 245-251.
14. Cohen, S.M., Ellwein, L.B., 1989. Cell proliferation in Carcinogenesis. Science 249, 1007-1011.
15. Concoran, G.B., Fix, L., Jones, D.P., et al., 1994. Contemporary issues in toxicology. Apoptosis: molecular control point in toxicity. Toxicol. Appl. Pharmacol. 128, 169-181.
16. Decker, K., 1990. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur. J. Biochem. 192, 245-261.
17. Elcombe, C.R., 1985. Species differences in carcinogenicity and peroxisome proliferation due to trichloroethylene: a biochemical human hazard assessment. Arch. Toxicol. Suppl. 8, 6-17.
18. Elcombe, C.R., Mitchell, A., 1986. Peroxisome proliferation due to di(2-ethyl) phthalate: species differences and possible mechanisms. Environ. Health Perspect. 70, 211-219.
19. Gerbracht, U., Bursch, W., Kraus, P., et al., 1990. Effects of the hypolipidaemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liver. Carcinogenesis 11, 617-624.
20. Gill, J.H., Roberts, R.A., Dive, C., 1998. The nongenotoxic hepatocarcinogen nafnopin suppresses rodent hepatocyte apoptosis induced by TGF$1. DNA damage and FAS. Carcinogenesis 19, 299-304.
21. Gonzalez, 1997. In: Dietary Fat and Cancer, vol. Plenum Press, New York, pp. 109-125.
22. Hanefeld, M., Hemmer, C., Kadner, E., 1983. Relationship between morphological changes and lipid lowering action of p-chlorophenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man. Atherosclerosis 46, 239-246.
23. Heller, R.A., Kronke, M., 1994. Tumor necrosis factor receptor-mediated signalling pathways. J. Cell Biol. 126, 5-9.
24. Issemann, I., Green, S., 1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347, 645-650.
25. James, N.H., Roberts, R.A., 1996. Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than with suppression of apoptosis. Carcinogenesis 17, 1623-1632.
26. Lake, B.G., Evans, J.G., Gray, T.J.B., Korosi, S.A., North, C.J., 1989. Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, syrian hamster, guinea pig and marmoset. Toxicol. Appl. Pharmacol. 99, 148-160.
27. Lee, S.S.T., Pineau, T., Drago, J., et al., 1995. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15, 3012-3022.
28. Marsmann, D.S., Cattley, R.C., Conway, J.G., Popp, J.A., 1988. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-pyramidinylthio] acetic acid (Wyeth-14,643) in rats. Cancer Res. 48, 6739-6744.
29. May, M.J., Ghosh, S., 1998. Signal transduction through NF-kappaB. Immunol. Today 19, 80-88.
30. Moody, D.E., Reddy, J.K., Lake, B.G., Popp, J.A., Reese, D.H., 1991. Peroxisome proliferation and non-genotoxic carcinogenesis: commentary on a symposium. Fund. Appl. Toxicol. 6, 233-248.
31. Oberhammer, F.A., Roberts, R.A., 1994. In: The Liver: Biology and Pathobiology, vol. Raven Press, New York, pp. 1547-1556.
32. Reddy, J.K., Lalwani, N.D., 1983. Carcinogenesis by hepatic peroxisome proliferators. Evaluation of the risk of hypolidaemic drugs and industrial plasticizers to humans. Crit. Rev. Toxicol. 12, 1-58.
33. Reddy, J.K., Azarnoff, D.L., Hignite, C.E., 1980. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 283, 397-398.
34. Roberts, R.A., 1996. In: Peroxisomes: Biology and Role in Toxicology and Disease, vol. 804. New York Academy of Sciences, New York, pp. 588-602.
35. Roberts, R.A., James, N.H., Woodyatt, N., Macdonald, N., Tugwood, J., 1998. Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPARa). Carcinogenesis 19, 43-48.
36. Rolfe, M., James, N.H., Roberts, R.A., 1997. Tumour necrosis factor alpha (TNF-alpha) suppresses apoptosis and induces S-phase in rodent hepatocytes: a mediator of the hepatocarcinogenicity of peroxisome proliferators?. Carcinogenesis 18, 2277-2280.
37. Tessitore, L., Bonelli, G., Baccino, F.M., 1987. Early development of protein metabolic perturbations in the liver and skeletal muscle of tumour-bearing rats. A model system for cancer cachexia. Biochem. J. 241, 153-159.
38. Tugwood, J.D., Issemann, I., Anderson, R.G., Bundell, K.R., McPheat, W.L., Green, S., 1992. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 11, 433-439.
39. Tugwood, J.D., Aldridge, T.C., Lambe, K.L., Macdonald, N., Woodyatt, N.J., 1996. In: Peroxisomes: Biology and Role in Toxicology and Disease, vol. 804. New York Academy of Sciences, New York, pp. 252-265.
40. Yamada, Y., Kirillova, I., Peschon, J.J., Fausto, N., 1997. Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc. Natl. Acad. Sci. 94, 141-1446.